Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Identification of genetic variants associated with skeletal muscle function deficit in childhood acute lymphoblastic leukemia survivors.

Nadeau G, Ouimet-Grennan E, Aaron M, Drouin S, Bertout L, Shalmiev A, Beaulieu P, St-Onge P, Veilleux LN, Rauch F, Petrykey K, Laverdière C, Sinnett D, Alos N, Krajinovic M.

Pharmgenomics Pers Med. 2019 Apr 11;12:33-45. doi: 10.2147/PGPM.S192924. eCollection 2019.

2.

Is there a relationship between vitamin D nutritional status and metabolic syndrome in childhood acute lymphoblastic leukemia survivors? A PETALE study.

Delvin E, Marcil V, Alos N, Laverdière C, Sinnett D, Krajinovic M, Bélanger V, Drouin S, Nyalendo C, Levy E.

Clin Nutr ESPEN. 2019 Jun;31:28-32. doi: 10.1016/j.clnesp.2019.03.006. Epub 2019 Apr 2.

PMID:
31060831
3.

Identification of a single-nucleotide polymorphism within CDH2 gene associated with bone morbidity in childhood acute lymphoblastic leukemia survivors.

Aaron M, Nadeau G, Ouimet-Grennan E, Drouin S, Bertout L, Beaulieu P, St-Onge P, Shalmiev A, Veilleux LN, Rauch F, Petrykey K, Laverdière C, Sinnett D, Alos N, Krajinovic M.

Pharmacogenomics. 2019 Apr;20(6):409-420. doi: 10.2217/pgs-2018-0169. Epub 2019 Apr 15.

PMID:
30983502
4.

Impact of two oral doses of 100,000 IU of vitamin D3 in preschoolers with viral-induced asthma: a pilot randomised controlled trial.

Ducharme FM, Jensen M, Mailhot G, Alos N, White J, Rousseau E, Tse SM, Khamessan A, Vinet B.

Trials. 2019 Feb 18;20(1):138. doi: 10.1186/s13063-019-3184-z.

5.

Prevention of Long-term Adverse Health Outcomes With Cardiorespiratory Fitness and Physical Activity in Childhood Acute Lymphoblastic Leukemia Survivors.

Lemay V, Caru M, Samoilenko M, Drouin S, Alos N, Lefebvre G, Levy E, Lippé S, Marcil V, Sultan S, Bertout L, Krajinovic M, Laverdière C, Raboisson MJ, Sinnett D, Andelfinger G, Curnier D.

J Pediatr Hematol Oncol. 2019 Jan 25. doi: 10.1097/MPH.0000000000001426. [Epub ahead of print]

PMID:
30688830
6.

The long-term impact of very preterm birth on adult bone mineral density.

Xie LF, Alos N, Cloutier A, Béland C, Dubois J, Nuyt AM, Luu TM.

Bone Rep. 2018 Dec 12;10:100189. doi: 10.1016/j.bonr.2018.100189. eCollection 2019 Jun.

7.

Impact of Vertebral Fractures and Glucocorticoid Exposure on Height Deficits in Children During Treatment of Leukemia.

Ma J, Siminoski K, Alos N, Halton J, Ho J, Cummings EA, Shenouda N, Matzinger MA, Lentle B, Jaremko JL, Wilson B, Stephure D, Stein R, Sbrocchi AM, Rodd C, Lewis VA, Laverdière C, Israels S, Grant RM, Fernandez CV, Dix DB, Couch R, Cairney E, Barr R, Atkinson S, Abish S, Moher D, Rauch F, Ward LM; Canadian STOPP Consortium.

J Clin Endocrinol Metab. 2019 Feb 1;104(2):213-222. doi: 10.1210/jc.2018-01083.

PMID:
30247635
8.

Vitamin D Intake and Status of Children With Sickle Cell Disease in Montreal, Canada.

Grégoire-Pelchat P, Alos N, Ribault V, Pastore Y, Robitaille N, Mailhot G.

J Pediatr Hematol Oncol. 2018 Nov;40(8):e531-e536. doi: 10.1097/MPH.0000000000001306.

PMID:
30212419
9.

Bone Morbidity and Recovery in Children With Acute Lymphoblastic Leukemia: Results of a Six-Year Prospective Cohort Study.

Ward LM, Ma J, Lang B, Ho J, Alos N, Matzinger MA, Shenouda N, Lentle B, Jaremko JL, Wilson B, Stephure D, Stein R, Sbrocchi AM, Rodd C, Lewis V, Israels S, Grant RM, Fernandez CV, Dix DB, Cummings EA, Couch R, Cairney E, Barr R, Abish S, Atkinson SA, Hay J, Rauch F, Moher D, Siminoski K, Halton J; Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) Consortium.

J Bone Miner Res. 2018 Aug;33(8):1435-1443. doi: 10.1002/jbmr.3447. Epub 2018 May 22.

PMID:
29786884
10.

Refining the phenotype associated with biallelic DNAJC21 mutations.

D'Amours G, Lopes F, Gauthier J, Saillour V, Nassif C, Wynn R, Alos N, Leblanc T, Capri Y, Nizard S, Lemyre E, Michaud JL, Pelletier VA, Pastore YD, Soucy JF.

Clin Genet. 2018 Aug;94(2):252-258. doi: 10.1111/cge.13370. Epub 2018 Jun 7.

PMID:
29700810
11.

Chitayat-Hall and Schaaf-Yang syndromes:a common aetiology: expanding the phenotype of MAGEL2-related disorders.

Jobling R, Stavropoulos DJ, Marshall CR, Cytrynbaum C, Axford MM, Londero V, Moalem S, Orr J, Rossignol F, Lopes FD, Gauthier J, Alos N, Rupps R, McKinnon M, Adam S, Nowaczyk MJM, Walker S, Scherer SW, Nassif C, Hamdan FF, Deal CL, Soucy JF, Weksberg R, Macleod P, Michaud JL, Chitayat D.

J Med Genet. 2018 May;55(5):316-321. doi: 10.1136/jmedgenet-2017-105222. Epub 2018 Mar 29.

PMID:
29599419
12.

Vitamin D nutritional status and bone turnover markers in childhood acute lymphoblastic leukemia survivors: A PETALE study.

Delvin E, Alos N, Rauch F, Marcil V, Morel S, Boisvert M, Lecours MA, Laverdière C, Sinnett D, Krajinovic M, Dubois J, Drouin S, Lefebvre G, Samoilenko M, Nyalendo C, Cavalier E, Levy E.

Clin Nutr. 2019 Apr;38(2):912-919. doi: 10.1016/j.clnu.2018.02.006. Epub 2018 Feb 21.

PMID:
29503055
13.

Influence of BCL2L11 polymorphism on osteonecrosis during treatment of childhood acute lymphoblastic leukemia.

Plesa M, Gagné V, Glisovic S, Younan M, Sharif-Askari B, Laverdière C, Alos N, Leclerc JM, Sallan SE, Neuberg D, Kutok JL, Silverman LB, Sinnett D, Krajinovic M.

Pharmacogenomics J. 2019 Feb;19(1):33-41. doi: 10.1038/s41397-017-0002-4. Epub 2017 Dec 27.

PMID:
29282361
14.

Two Cases of Mistaken Polyuria and Nephrocalcinosis in Infants with Glucose-Galactose Malabsorption: A Possible Role of 1,25(OH)2D3
.

Fiscaletti M, Lebel MJ, Alos N, Benoit G, Jantchou P.

Horm Res Paediatr. 2017;87(4):277-282. doi: 10.1159/000454951. Epub 2017 Feb 2.

PMID:
28152538
15.

The PETALE study: Late adverse effects and biomarkers in childhood acute lymphoblastic leukemia survivors.

Marcoux S, Drouin S, Laverdière C, Alos N, Andelfinger GU, Bertout L, Curnier D, Friedrich MG, Kritikou EA, Lefebvre G, Levy E, Lippé S, Marcil V, Raboisson MJ, Rauch F, Robaey P, Samoilenko M, Séguin C, Sultan S, Krajinovic M, Sinnett D.

Pediatr Blood Cancer. 2017 Jun;64(6). doi: 10.1002/pbc.26361. Epub 2016 Dec 4.

PMID:
27917589
16.

Pediatric data for dual X-ray absorptiometric measures of normal lumbar bone mineral density in children under 5 years of age using the lunar prodigy densitometer.

Manousaki D, Rauch F, Chabot G, Dubois J, Fiscaletti M, Alos N.

J Musculoskelet Neuronal Interact. 2016 Sep 7;16(3):247-55.

17.

Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial.

Jensen ME, Mailhot G, Alos N, Rousseau E, White JH, Khamessan A, Ducharme FM.

Trials. 2016 Jul 26;17(1):353. doi: 10.1186/s13063-016-1483-1.

18.

Cow's Milk Allergy and Bone Mineral Density in Prepubertal Children.

Mailhot G, Perrone V, Alos N, Dubois J, Delvin E, Paradis L, Des Roches A.

Pediatrics. 2016 May;137(5). pii: e20151742. doi: 10.1542/peds.2015-1742.

19.

Incident Vertebral Fractures in Children With Leukemia During the Four Years Following Diagnosis.

Cummings EA, Ma J, Fernandez CV, Halton J, Alos N, Miettunen PM, Jaremko JL, Ho J, Shenouda N, Matzinger MA, Lentle B, Stephure D, Stein R, Sbrocchi AM, Rodd C, Lang B, Israels S, Grant RM, Couch R, Barr R, Hay J, Rauch F, Siminoski K, Ward LM; Canadian STOPP Consortium (National Pediatric Bone Health Working Group).

J Clin Endocrinol Metab. 2015 Sep;100(9):3408-17. doi: 10.1210/JC.2015-2176. Epub 2015 Jul 14.

20.

Incident Vertebral Fractures and Risk Factors in the First Three Years Following Glucocorticoid Initiation Among Pediatric Patients With Rheumatic Disorders.

LeBlanc CM, Ma J, Taljaard M, Roth J, Scuccimarri R, Miettunen P, Lang B, Huber AM, Houghton K, Jaremko JL, Ho J, Shenouda N, Matzinger MA, Lentle B, Stein R, Sbrocchi AM, Oen K, Rodd C, Jurencak R, Cummings EA, Couch R, Cabral DA, Atkinson S, Alos N, Rauch F, Siminoski K, Ward LM; Canadian STeroid-Associated Osteoporosis in Pediatric Population (STOPP) Consortium.

J Bone Miner Res. 2015 Sep;30(9):1667-75. doi: 10.1002/jbmr.2511. Epub 2015 May 26.

22.

The choice of normative pediatric reference database changes spine bone mineral density Z-scores but not the relationship between bone mineral density and prevalent vertebral fractures.

Ma J, Siminoski K, Alos N, Halton J, Ho J, Lentle B, Matzinger M, Shenouda N, Atkinson S, Barr R, Cabral DA, Couch R, Cummings EA, Fernandez CV, Grant RM, Rodd C, Sbrocchi AM, Scharke M, Rauch F, Ward LM; Canadian STOPP Consortium.

J Clin Endocrinol Metab. 2015 Mar;100(3):1018-27. doi: 10.1210/jc.2014-3096. Epub 2014 Dec 11.

23.

A 15-year-old adolescent with a rare pituitary lesion.

Manousaki D, Deal C, De Bruycker JJ, Ovetchkine P, Mercier C, Alos N.

Endocrinol Diabetes Metab Case Rep. 2014;2014:140010. doi: 10.1530/EDM-14-0010. Epub 2014 May 1.

24.

Association between lean and fat mass and indicators of bone health in prepubertal caucasian children.

Kâ K, Rousseau MC, Lambert M, O'Loughlin J, Henderson M, Tremblay A, Alos N, Nicolau B.

Horm Res Paediatr. 2013;80(3):154-62. doi: 10.1159/000354043. Epub 2013 Aug 28.

PMID:
23988728
25.

Skeletal findings in the first 12 months following initiation of glucocorticoid therapy for pediatric nephrotic syndrome.

Phan V, Blydt-Hansen T, Feber J, Alos N, Arora S, Atkinson S, Bell L, Clarson C, Couch R, Cummings EA, Filler G, Grant RM, Grimmer J, Hebert D, Lentle B, Ma J, Matzinger M, Midgley J, Pinsk M, Rodd C, Shenouda N, Stein R, Stephure D, Taback S, Williams K, Rauch F, Siminoski K, Ward LM; Canadian STOPP Consortium.

Osteoporos Int. 2014 Feb;25(2):627-37. doi: 10.1007/s00198-013-2466-7. Epub 2013 Aug 16.

26.

A search for variables predicting cortisol response to low-dose corticotropin stimulation following supraphysiological doses of glucocorticoids.

Wildi-Runge S, Deladoëy J, Bélanger C, Deal CL, Van Vliet G, Alos N, Huot C.

J Pediatr. 2013 Aug;163(2):484-8. doi: 10.1016/j.jpeds.2013.01.011. Epub 2013 Feb 12.

PMID:
23414662
27.

Rising serum thyroxine levels and chorea in graves' disease.

Leblicq C, Duval M, Carmant L, Van Vliet G, Alos N.

Pediatrics. 2013 Feb;131(2):e616-9. doi: 10.1542/peds.2012-0686. Epub 2013 Jan 6.

PMID:
23296438
28.

Effectiveness of pamidronate as treatment of symptomatic osteonecrosis occurring in children treated for acute lymphoblastic leukemia.

Leblicq C, Laverdière C, Décarie JC, Delisle JF, Isler MH, Moghrabi A, Chabot G, Alos N.

Pediatr Blood Cancer. 2013 May;60(5):741-7. doi: 10.1002/pbc.24313. Epub 2012 Sep 21.

PMID:
23002054
29.

Glucocorticoid-related changes in body mass index among children and adolescents with rheumatic diseases.

Shiff NJ, Brant R, Guzman J, Cabral DA, Huber AM, Miettunen P, Roth J, Scuccimarri R, Alos N, Atkinson SA, Collet JP, Couch R, Cummings EA, Dent PB, Ellsworth J, Hay J, Houghton K, Jurencak R, Lang B, Larche M, Leblanc C, Rodd C, Saint-Cyr C, Stein R, Stephure D, Taback S, Rauch F, Ward LM; Canadian Steroid-associated Osteoporosis in the Pediatric Population Consortium.

Arthritis Care Res (Hoboken). 2013 Jan;65(1):113-21. doi: 10.1002/acr.21785.

30.

The development of bone mineral lateralization in the arms.

Siminoski K, Lee KC, Abish S, Alos N, Bell L, Blydt-Hansen T, Couch R, Cummings EA, Ellsworth J, Feber J, Fernandez CV, Halton J, Huber AM, Israels S, Jurencak R, Lang B, Laverdière C, LeBlanc C, Lewis V, Midgley J, Miettunen PM, Oen K, Phan V, Pinsk M, Rauch F, Rodd C, Roth J, Saint-Cyr C, Scuccimarri R, Stephure D, Taback S, Wilson B, Ward LM; Canadian STOPP Consortium National Pediatric Bone Health Working Group.

Osteoporos Int. 2013 Mar;24(3):999-1006. doi: 10.1007/s00198-012-2054-2. Epub 2012 Jun 29.

31.

High incidence of vertebral fractures in children with acute lymphoblastic leukemia 12 months after the initiation of therapy.

Alos N, Grant RM, Ramsay T, Halton J, Cummings EA, Miettunen PM, Abish S, Atkinson S, Barr R, Cabral DA, Cairney E, Couch R, Dix DB, Fernandez CV, Hay J, Israels S, Laverdière C, Lentle B, Lewis V, Matzinger M, Rodd C, Shenouda N, Stein R, Stephure D, Taback S, Wilson B, Williams K, Rauch F, Siminoski K, Ward LM.

J Clin Oncol. 2012 Aug 1;30(22):2760-7. doi: 10.1200/JCO.2011.40.4830. Epub 2012 Jun 25.

32.

Incident vertebral fractures among children with rheumatic disorders 12 months after glucocorticoid initiation: a national observational study.

Rodd C, Lang B, Ramsay T, Alos N, Huber AM, Cabral DA, Scuccimarri R, Miettunen PM, Roth J, Atkinson SA, Couch R, Cummings EA, Dent PB, Ellsworth J, Hay J, Houghton K, Jurencak R, Larché M, LeBlanc C, Oen K, Saint-Cyr C, Stein R, Stephure D, Taback S, Lentle B, Matzinger M, Shenouda N, Moher D, Rauch F, Siminoski K, Ward LM; Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) Consortium.

Arthritis Care Res (Hoboken). 2012 Jan;64(1):122-31. doi: 10.1002/acr.20589.

33.

Muscle-bone characteristics in children with Prader-Willi syndrome.

Edouard T, Deal C, Van Vliet G, Gaulin N, Moreau A, Rauch F, Alos N.

J Clin Endocrinol Metab. 2012 Feb;97(2):E275-81. doi: 10.1210/jc.2011-2406. Epub 2011 Dec 7.

PMID:
22162467
34.

Efficacy and safety of 2-year etidronate treatment in a child with generalized arterial calcification of infancy.

Edouard T, Chabot G, Miro J, Buhas DC, Nitschke Y, Lapierre C, Rutsch F, Alos N.

Eur J Pediatr. 2011 Dec;170(12):1585-90. doi: 10.1007/s00431-011-1572-9. Epub 2011 Sep 20.

PMID:
21932012
35.

Skeletal findings in children recently initiating glucocorticoids for the treatment of nephrotic syndrome.

Feber J, Gaboury I, Ni A, Alos N, Arora S, Bell L, Blydt-Hansen T, Clarson C, Filler G, Hay J, Hebert D, Lentle B, Matzinger M, Midgley J, Moher D, Pinsk M, Rauch F, Rodd C, Shenouda N, Siminoski K, Ward LM; Canadian STOPP Consortium.

Osteoporos Int. 2012 Feb;23(2):751-60. doi: 10.1007/s00198-011-1621-2. Epub 2011 Apr 15.

36.

Is ultrasonography useful in predicting thyroid cancer in children with thyroid nodules and apparently benign cytopathologic features?

Saavedra J, Deladoëy J, Saint-Vil D, Boivin Y, Alos N, Deal C, Van Vliet G, Huot C.

Horm Res Paediatr. 2011;75(4):269-75. doi: 10.1159/000322877. Epub 2011 Jan 20.

PMID:
21252476
37.

Short- and long-term outcome of patients with pseudo-vitamin D deficiency rickets treated with calcitriol.

Edouard T, Alos N, Chabot G, Roughley P, Glorieux FH, Rauch F.

J Clin Endocrinol Metab. 2011 Jan;96(1):82-9. doi: 10.1210/jc.2010-1340. Epub 2010 Oct 6.

PMID:
20926527
38.

Non-immune goiter and hypothyroidism in a 19-week fetus: a plea for conservative treatment.

Stoppa-Vaucher S, Francoeur D, Grignon A, Alos N, Pohlenz J, Hermanns P, Van Vliet G, Deladoëy J.

J Pediatr. 2010 Jun;156(6):1026-1029. doi: 10.1016/j.jpeds.2010.01.018. Epub 2010 Mar 20.

PMID:
20304420
39.

The International Research Society of Spinal Deformities (IRSSD) and its contribution to science.

Bagnall KM, Grivas TB, Alos N, Asher M, Aubin CE, Burwell GR, Dangerfield PH, Edouard T, Hill D, Lou E, Moreau A, O'Brien J, Stokes I, Weiss HR, Raso J.

Scoliosis. 2009 Dec 22;4:28. doi: 10.1186/1748-7161-4-28.

40.

Comparison of adolescents with Klinefelter syndrome according to the circumstances of diagnosis: amniocentesis versus clinical signs.

Girardin CM, Lemyre E, Alos N, Deal C, Huot C, Van Vliet G.

Horm Res. 2009;72(2):98-105. doi: 10.1159/000232162. Epub 2009 Aug 18.

PMID:
19690427
41.

[Bone mass acquisition in children: pathophysiology and evaluation].

Alos N, Rauch F.

Arch Pediatr. 2009 Jun;16(6):591-3. doi: 10.1016/S0929-693X(09)74078-3. French. No abstract available.

PMID:
19541096
42.

Do estrogens impact adolescent idiopathic scoliosis?

Leboeuf D, Letellier K, Alos N, Edery P, Moldovan F.

Trends Endocrinol Metab. 2009 May;20(4):147-52. doi: 10.1016/j.tem.2008.12.004. Epub 2009 Apr 6.

PMID:
19349194
43.

Advanced vertebral fracture among newly diagnosed children with acute lymphoblastic leukemia: results of the Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) research program.

Halton J, Gaboury I, Grant R, Alos N, Cummings EA, Matzinger M, Shenouda N, Lentle B, Abish S, Atkinson S, Cairney E, Dix D, Israels S, Stephure D, Wilson B, Hay J, Moher D, Rauch F, Siminoski K, Ward LM; Canadian STOPP Consortium.

J Bone Miner Res. 2009 Jul;24(7):1326-34. doi: 10.1359/jbmr.090202.

44.

Preemptive use of high-dose fluticasone for virus-induced wheezing in young children.

Ducharme FM, Lemire C, Noya FJ, Davis GM, Alos N, Leblond H, Savdie C, Collet JP, Khomenko L, Rivard G, Platt RW.

N Engl J Med. 2009 Jan 22;360(4):339-53. doi: 10.1056/NEJMoa0808907.

45.

Enzyme replacement therapy in pediatric patients with Gaucher disease: what should we use as maintenance dosage?

Brunel-Guitton C, Rivard GE, Galipeau J, Alos N, Miron MC, Therrien R, Mitchell G, Lapierre G, Lambert M.

Mol Genet Metab. 2009 Feb;96(2):73-6. doi: 10.1016/j.ymgme.2008.11.158. Epub 2008 Dec 10.

PMID:
19083253
46.

Impact of patient characteristics and clinical factors on the decision to initiate growth hormone treatment in Turner syndrome.

Khatchadourian K, Huot C, Alos N, Van Vliet G, Deal C.

Horm Res. 2008;70(5):300-8. doi: 10.1159/000157877. Epub 2008 Sep 30.

PMID:
18824869
47.

Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum.

Cole LW, Sidis Y, Zhang C, Quinton R, Plummer L, Pignatelli D, Hughes VA, Dwyer AA, Raivio T, Hayes FJ, Seminara SB, Huot C, Alos N, Speiser P, Takeshita A, Van Vliet G, Pearce S, Crowley WF Jr, Zhou QY, Pitteloud N.

J Clin Endocrinol Metab. 2008 Sep;93(9):3551-9. doi: 10.1210/jc.2007-2654. Epub 2008 Jun 17.

48.

Cumulative doses of adjunct 131I treatment depend on location of residual thyroid tissue after total thyroidectomy in differentiated thyroid cancer.

Saint-Vil D, Emran MA, Lambert R, Alos N, Turpin S, Huot C.

J Pediatr Surg. 2007 May;42(5):853-6.

PMID:
17502198
49.

Pamidronate: Treatment for severe hypercalcemia in neonatal subcutaneous fat necrosis.

Alos N, Eugène D, Fillion M, Powell J, Kokta V, Chabot G.

Horm Res. 2006;65(6):289-94. Epub 2006 Apr 6.

PMID:
16612105
50.

Downregulation of osteoblast Phex expression by PTH.

Alos N, Ecarot B.

Bone. 2005 Oct;37(4):589-98.

PMID:
16084134

Supplemental Content

Support Center